No Data
Earnings Preview: LifeMD to Report Financial Results Post-market on November 07
$LifeMD(LFMD.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $LifeMD(LFMD.US)$ to post revenue of USD53.80M for 2024Q3, up 39.32%
Press Release: LifeMD(R) to Report Third Quarter 2024 Financial Results on November 7
Express News | LifeMD® Launches Testorx, a New Rex Md® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering
LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
No Data
No Data